Our mission is to support researchers and clinicians in their work towards finding a cure for RET-Positive Non-Small Cell Lung Cancer, while educating and empowering patients in their own healing journey.
Our focus is on funding initiatives to:
- Raise awareness about testing methods for early detection of NSCLC mutations, which will facilitate targeted therapy and improve patient outcomes.
- Develop individualized therapies based upon new testing and diagnostics, including methods to combat development of targeted therapy resistance.
- Determine if existing pharmaceuticals can be repurposed or combined with other treatments to provide effective, novel treatments.
- Develop new immunotherapies which can be used in conjunction with existing treatments, or employed as primary therapy.
Additionally, we will collaborate with researchers and clinicians to determine the applicability of our efforts to other genetic mutations or cancers caused by the RET mutation (e.g. thyroid cancer), while alerting patients and their families to new clinical trials which may create the next generation of life saving treatments.